...
首页> 外文期刊>Journal of Bioscience and Bioengineering >Development of human-derived hemoglobin-albumin microspheres as oxygen carriers using Shirasu porous glass membrane emulsification
【24h】

Development of human-derived hemoglobin-albumin microspheres as oxygen carriers using Shirasu porous glass membrane emulsification

机译:使用Shirasu多孔玻璃膜乳化的人源性血红蛋白 - 白蛋白微球作为氧载体的发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Novel hemoglobin-based artificial oxygen carriers are necessary in tissue engineering. We developed human hemoglobin (hHb) and albumin (HSA)-based microspheres using Shirasu porous glass (SPG) membrane emulsification. The obtained microspheres had a uniform size with an average diameter of 15.1 gm measured by optical microscope, which is similar to the diameter of human red blood cells (7-8 mu m). The loading amount of hHb in the microspheres was 20 wt%, which is similar to that of red blood cells (33 wt%). The hHb HSA microspheres showed similar oxygen dissociation behavior and methemoglobin formation resistance to native hHb. Incubation with genetically engineered HeLa cells that shows hypoxia-responsive EGFP expression demonstrated efficient oxygen supply from the microspheres. Our study suggests the utility of hHb HSA microspheres as oxygen carriers for tissue engineering with a low risk of infectious disease. (C) 2018, The Society for Biotechnology, Japan. All rights reserved.
机译:基于新型的血红蛋白的人工氧载体是组织工程所必需的。 使用Shirasu多孔玻璃(SPG)膜乳化,我们开发了人血红蛋白(HHB)和白蛋白(HSA)基础的微球。 所获得的微球具有均匀的尺寸,通过光学显微镜测量的平均直径为15.1克,其类似于人红细胞的直径(7-8μm)。 微球中HHB的加载量为20wt%,其类似于红细胞(33wt%)。 HHB HSA微球显示出与天然HHB相似的氧解离行为和甲型飞石宾蛋白形成抗性。 孵育与遗传工程的HELA细胞显示缺氧响应性EGFP表达表达,从微球中表现出有效的氧气供应。 我们的研究表明HHB HSA微球的效用作为具有低风险性疾病的组织工程的氧载体。 (c)2018年,日本生物技术协会。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号